Johnson & Johnson | Sustainability Performance
Develops and markets pharmaceuticals, medical devices, and consumer healthcare products.
1886
United States
10,001+ employees
Medical Device
$10B+ in revenue
$10B+ in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4164
Overallⓘ#890
in United Statesⓘ#54
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsCarbon certificatesEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
TargetsSDG ImpactESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projectionsAsset manager exclusion
Aligned
Aligned
Aligned
Leading
Leading
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Industry Benchmark
7.9
B/M 12.7
68.9
B/M 163.1
31.0
B/M 24.0
Powered by illuminem and GIST Impact
Controversy level
- Johnson & Johnson paid over USD 9 billion to settle tens of thousands of talcrelated ovarian cancer and mesothelioma claims, with the company pursuing multiple bankruptcy strategies for liability resolution.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.